Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus to reduce calcineurin inhibitor dose in lung transplant recipients with chronic renal insufficiency
2006-001945-32Phase 4Completed
- Sponsor
- Erasmus Hospital
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of everolimus in chronic kidney disease (CKD), lung transplantation, Bronchiolitis Obliterans Syndrome (BOS) and 1 more, sponsored by Erasmus Hospital. Primary endpoint: EFR. Started Oct 2006; status: completed.
02
Drugs
everolimus
03
Conditions
chronic kidney disease (CKD)lung transplantationBronchiolitis Obliterans Syndrome (BOS)Lung allograft rejection (LAR)
Beyond the preview
Go deeper on 2006-001945-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001945-32.